Literature DB >> 23786929

Risk factors for adult death due to 2009 pandemic influenza A (H1N1) virus infection: a 2151 severe and critical cases analysis.

Peng-Jun Zhang1, Bin Cao, Xiao-Li Li, Li-Rong Liang, Shi-Gui Yang, Li Gu, Zhen Xu, Ke Hu, Hong-Yuan Zhang, Xi-Xin Yan, Wen-Bao Huang, Wei Chen, Jing-Xiao Zhang, Lan-Juan Li, Chen Wang.   

Abstract

BACKGROUND: The 2009 pandemic H1N1 (pH1N1) influenza showed that relatively young adults accounted for the highest rates of hospital admission and death. In preparation for pH1N1, the aim of the study is to identify factors associated with the mortality of patients with 2009 pH1N1 infection, especially for young patients without chronic medical conditions.
METHODS: Retrospective observational study of 2151 severe or critical adult cases (≥ 14 years old) admitted to a hospital with pH1N1 influenza from September 1, 2009 to December 31, 2009 from 426 hospitals of 27 Chinese provinces. A confirmed case was a person whose pH1N1 virus infection was verified by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Severe and critical cases were defined according to the H1N1 2009 Clinical guidelines (Third Edition, 2009) released by the Ministry of Health of China.
RESULTS: Among the 2151 patients, the mean age was 34.0 years. Two hundred and ninty-three (13.6%) died during hospital stay. One thousand four hundred and forty-two patients (67.0%) had no comorbidities and 189 (13.1%) of them died. Pregnancy (OR 8.03), pneumonia (OR 8.91), dyspnea (OR 3.95), central nervous system (CNS) symptom (OR 1.55), higher APACHE (Acute Physiology and Chronic Health Evaluation) II score (OR 1.06), Alanine aminotransferase (ALT) (OR 1.002), and the lactate dehydrogenase (LDH) level (OR 1.001) were independent risk factors for death among adults without chronic medical conditions. Higher APACHE II score (OR 1.08) and age (OR 1.06) were independent risk factors for death among adults with respiratory diseases. A multivariate analysis showed an association between mortality and CNS symptoms (OR 2.66), higher APACHE II score (OR 1.03), ALT (OR 1.006), and LDH level (OR 1.002) in patients with cardiovascular diseases. Dyspnea (OR 11.32) was an independent risk factor for patient death in patients with diabetes mellitus.
CONCLUSION: Clinical knowledge of identified prognostic factors for mortality may aid in the management of adult influenza infection.

Entities:  

Mesh:

Year:  2013        PMID: 23786929

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Authors:  Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby
Journal:  Am J Reprod Immunol       Date:  2017-06-20       Impact factor: 3.886

2.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Louise Lansbury; Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2019-02-24

3.  Thin-section computed tomography detects long-term pulmonary sequelae 3 years after novel influenza A virus-associated pneumonia.

Authors:  Zhi-Heng Xing; Xin Sun; Long Xu; Qi Wu; Li Li; Xian-Jie Wu; Xu-Guang Shao; Xin-Qian Zhao; Jing-Hua Wang; Long-Yan Ma; Kai Wang
Journal:  Chin Med J (Engl)       Date:  2015-04-05       Impact factor: 2.628

4.  Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.

Authors:  Francisco Álvarez-Lerma; Judith Marín-Corral; Clara Vila; Joan Ramón Masclans; Francisco Javier González de Molina; Ignacio Martín Loeches; Sandra Barbadillo; Alejandro Rodríguez
Journal:  Crit Care       Date:  2016-10-23       Impact factor: 9.097

Review 5.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

6.  Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Authors:  Yi Zhang; Wenjie Sun; Erik R Svendsen; Song Tang; Raina C MacIntyre; Peng Yang; Daitao Zhang; Quanyi Wang
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 19.334

7.  Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis.

Authors:  Brenda L Coleman; Shaza A Fadel; Tiffany Fitzpatrick; Sera-Melisa Thomas
Journal:  Influenza Other Respir Viruses       Date:  2017-12-02       Impact factor: 4.380

8.  A retrospective study on the epidemiological characteristics and establishment of an early warning system of severe COVID-19 patients.

Authors:  Ping Yang; Pengfei Wang; Yuyan Song; An Zhang; Guodan Yuan; Yong Cui
Journal:  J Med Virol       Date:  2020-06-02       Impact factor: 20.693

9.  Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol.

Authors:  Hua Zhou; Huibin Huang; Xiaolei Xie; Jiandong Gao; Ji Wu; Yan Zhu; Wei He; Jingyuan Liu; Ang Li; Yuan Xu
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

10.  Hospital utilization rates for influenza and RSV: a novel approach and critical assessment.

Authors:  Emily K Johnson; Dillon Sylte; Sandra S Chaves; You Li; Cedric Mahe; Harish Nair; John Paget; Tayma van Pomeren; Ting Shi; Cecile Viboud; Spencer L James
Journal:  Popul Health Metr       Date:  2021-06-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.